KAITLYN MOORE: Open Payments
NPI 1811368939 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 9 payments from 7 companies in 2025. Trend: 2023 $5,004 · 2024 $1,088 · 2025 $203
Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| BeOne Medicines USA, Inc. | 1 | $34 |
| Genentech USA, Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Stemline Therapeutics Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
Products named: LUTATHERA, BRUKINSA, Polivy, ENHERTU, Orserdu, KISQALI, Padcev, IMBRUVICA.
Industry payments across GA — which companies pay providers there.
